Patent ID: 11944605
Assignee: JANSSEN PHARMACEUTICA NV
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 0:
1. A method of alleviating or inhibiting the progress of disease, disorder, or condition that is diabetic nephropathy, a kidney-related complication of type 1 diabetes, a kidney-related complication of type 2 diabetes, autosomal dominant polycystic kidney disease, autosomal recessive polycystic kidney disease, a kidney disease associated with cyst formation, a kidney disease associated with cystogenesis, focal segmental glomerulosclerosis, or a disease associated with sclerosis of the kidney in a patient in need thereof, comprising administering to said patient a compound of Formula II:, or a pharmaceutically acceptable salt thereof, wherein:
R1 is selected from,